Naturally-acquired immunity to Neisseria meningitidis group A

Vaccine

Volumn 23, Issue 8, 2005, Pages 977-983

  Amir, Jacob ^a   Louie, Lesile ^b   Granoff, Dan M ^b,c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c CA 94609 USA ^*  (United States)

Author keywords

Bactericidal activity; IgA anticapsular antibody; Meningococcal vaccine; Sub Saharan Africa

Indexed keywords

CROSS REACTING ANTIBODY; IMMUNOGLOBULIN A;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; FEMALE; GEOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; UGANDA;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BLOOD BACTERICIDAL ACTIVITY; HUMANS; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP A; NORTH AMERICA; SUDAN; UGANDA;

EID: 11144276001     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.07.042     Document Type: Article

References (42)

1. B. Greenwood, Manson, and Lecture Meningococcal meningitis in Africa Trans R Soc Trop Med Hyg 93 4 1999 341 353
2. P.L. Raghunathan, S.A. Bernhardt, and N.E. Rosenstein Opportunities for control of meningococcal disease in the United States Annu Rev Med 55 2004 333 353
3. B.M. Greenwood, I.S. Blakebrough, A.K. Bradley, S. Wali, and H.C. Whittle Meningococcal disease and season in sub-Saharan Africa Lancet 1 8390 1984 1339 1342
4. K. Cartwright, N. Noah, and H. Peltola Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting, 2000 October 6-8, Vienna, Austria Vaccine 19 31 2001 4347 4356
5. J. Decosas, and J.B. Koama Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso Lancet Infect Dis 2 12 2002 763 765
6. M.C. Maiden, and J.M. Stuart Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination Lancet 359 9320 2002 1829 1831
7. S.E. Kellerman, K. McCombs, M. Ray, W. Baughman, M.W. Reeves, and T. Popovic Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease J Infect Dis 186 1 2002 40 48
8. J.B. Robbins, L. Myerowitz, J.K. Whisnant, M. Argaman, R. Schneerson, and Z.T. Handzel Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3 Infect Immun 6 5 1972 651 656
9. W.F. Vann, T.Y. Liu, and J.B. Robbins Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide Infect Immun 13 6 1976 1654 1662
10. N. Guirguis, R. Schneerson, A. Bax, W. Egan, J.B. Robbins, and J. Shiloach Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis Immunochemical, biological, and epidemiological studies. J Exp Med 162 6 1985 1837 1851
11. I. Goldschneider, E.C. Gotschlich, and M.S. Artenstein Human immunity to the meningococcusI The role of humoral antibodies J Exp Med 129 6 1969 1307 1326
12. Ismail, AA, Harris, SL, Granoff, DM. Serum group A anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic. Pediatr Infect Dis J 2004;23(8):748-55.
13. A. Santaniello-Newton, and P.R. Hunter Management of an outbreak of meningococcal meningitis in a Sudanese refugee camp in Northern Uganda Epidemiol Infect 124 1 2000 75 81
14. C.A. Hart, and L.E. Cuevas Meningococcal disease in Africa Ann Trop Med Parasitol 91 7 1997 777 785
15. W.J. King, N.E. MacDonald, G. Wells, J. Huang, U. Allen, and F. Chan Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children J Pediatr 128 2 1996 196 202
16. Granoff, DM, Harris, SL. Protective activity of group C anticapsular antibodies elicited in 2 year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid vonjugate vaccine. Pediatr Infect Dis J 2004;23 (in press).
17. S.L. Harris, A. Finn, and D.M. Granoff Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid Conjugate vaccine and by a polysaccharide vaccine Infect Immun 71 6 2003 3402 3408
18. P.K. Holder, S.E. Maslanka, L.B. Pais, J. Dykes, B.D. Plikaytis, and G.M. Carlone Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992 Clin Diagn Lab Immunol 2 2 1995 132 137
19. J.F. Wang, D.A. Caugant, X. Li, X. Hu, J.T. Poolman, and B.A. Crowe Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China Infect Immun 60 12 1992 5267 5282
20. J.A. Welsch, R. Rossi, M. Comanducci, and D.M. Granoff Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine J Immunol 172 9 2004 5606 5615
21. G.A. Jarvis, and J.M. Griffiss Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule J Immunol 147 6 1991 1962 1967
22. J.M. Griffiss Bactericidal activity of meningococcal antisera Blocking by IgA of lytic antibody in human convalescent sera J Immunol 114 6 1975 1779 1784
23. J.R. Lingappa, N. Rosenstein, E.R. Zell, K.A. Shutt, A. Schuchat, and B.A. Perkins Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States Vaccine 19 31 2001 4566 4575
24. Granoff, D, Feavers, I, Borrow, R. Meningococcal Vaccines. In: Plotkin, SA, Orenstein, WA, editors.Vaccines. W. B. Saunders Company, Philadelphia, 2003.
25. Y. Schlesinger, D.M. Granoff, and Avidity bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines The Vaccine Study Group Jama 267 11 1992 1489 1494
26. W.R. Usinger, and A.H. Lucas Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides Infect Immun 67 5 1999 2366 2370
27. S.L. Harris, W.J. King, W. Ferris, and D.M. Granoff Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine Infect Immun 71 1 2003 275 286
28. A.H. Lucas, and D.M. Granoff Functional differences in idiotypically defined IgG1 anti- polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type b polysaccharide-protein conjugates J Immunol 154 8 1995 4195 4202
29. Z. Jin, C. Chu, J.B. Robbins, and R. Schneerson Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice Infect Immun 71 9 2003 5115 5120
30. B.M. Greenwood, A.M. Greenwood, A.K. Bradley, K. Williams, M. Hassan-King, and F.C. Shenton Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia West Africa. J Infect 14 2 1987 167 184
31. G.A. Filice, P.S. Hayes, G.W. Counts, J.M. Griffiss, and D.W. Fraser Risk of group A meningococcal disease: bacterial interference and cross- reactive bacteria among mucosal flora J Clin Microbiol 22 2 1985 152 156
32. J.M. Griffiss Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model Rev Infect Dis 4 1 1982 159 172
33. H. Peltola, H. Makela, H. Kayhty, H. Jousimies, E. Herva, and K. Hallstrom Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age N Engl J Med 297 13 1977 686 691
34. M. Achtman, A. van der Ende, P. Zhu, I.S. Koroleva, B. Kusecek, and G. Morelli Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997 Emerg Infect Dis 7 3 2001 420 427
35. K.R. Neal, J.S. Nguyen-Van-Tam, N. Jeffrey, R.C. Slack, R.J. Madeley, and K. Ait-Tahar Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study BMJ 320 7238 2000 846 849
36. D.S. Stephens Uncloaking the meningococcus: dynamics of carriage and disease Lancet 353 9157 1999 941 942
37. J.B. Robbins, R. Schneerson, E.C. Gotschlich, I. Mohammed, A. Nasidi, and J.P. Chippaux Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines Bull World Health Organ 81 2003 745 750
38. M.E. Birmingham, R.F. Lewis, W. Perea, C.B. Nelson, A. Kabore, and D. Tarantola Routine vaccination with polysaccharide meningococcal vaccines is an ineffective and possibly harmful strategy Bull World Health Organ 81 10 2003 751 752
39. N.E. Rosenstein, and B.A. Perkins Conjugate meningococcal vaccines offer a much more promising alternative Bull World Health Organ 81 10 2003 752 753
40. M.F. LaForce Control of epidemic meningitis in sub-Saharan Africa: our solution is more practical and affordable Bull World Health Organ 81 10 2003 753 754
41. M. Achtman Successful prevention of meningitis in Africa will need more than a vaccination strategy Bull World Health Organ 81 10 2003 754 755
42. S. Bugri Meningococcal meningitis vaccination: more information needed Bull World Health Organ 81 10 2003 755